Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06770998 · ClinicalTrials.gov registry record · NA

A Study of a Novel EEG Neurofeedback System for PTSD Treatment

A NA study of Stress Disorders, Post-Traumatic, sponsored by Foundation for Atlanta Veterans Education and Research.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
6
Study locations

NCT06770998: Recruiting NA study of Stress Disorders, Post-Traumatic, sponsored by Foundation for Atlanta Veterans Education and Research.

NCT06770998 is a NA study of Stress Disorders, Post-Traumatic that is actively recruiting participants, run by Foundation for Atlanta Veterans Education and Research. The registered enrollment target is 250 participants, above the 152-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (64% higher). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06770998, a NA study of Stress Disorders, Post-Traumatic, is actively recruiting participants, sponsored by Foundation for Atlanta Veterans Education and Research.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
6
Study locations

Study Summary

The goal of this clinical trial is to learn if training with the Prism system can reduce PTSD symptoms in US military Veterans and civilians with PTSD. Prism is a form of neurofeedback training that uses EEG signals to promote self-regulation of brain function. The main question this study aims to answer is: Does Prism training lead to decreased PTSD symptoms in US Veterans and civilians when used in addition to usual PTSD treatment? Researchers will compare Prism training to a sham training (a look-alike training that does not provide real feedback on brain activity) to see if Prism training decreases PTSD symptoms. Participants will: * Complete two one-hour in-person training sessions a week for about 8 weeks (15 sessions) * Complete two booster training sessions one month and two months after finishing the main training course * Participate in three detailed interviews: one before training, a second after nine weeks of training, and a third one month after the last booster training session (about 20 weeks after the initial visit)

Primary Outcome

Participants will take the Clinician-Administered PTSD Scale for DSM-5 Revised (the CAPS-5-R) before beginning Prism training. The CAPS-5-R assesses PTSD symptom severity with total scores that range from 0-80, with higher scores indicating more severe symptoms. There are multiple ways to score the CAPS-5-R; this study will score the CAPS-5-R using the same 0-80 score range used on the CAPS-5 (the previous version of the same assessment) so that the results from this study can be more easily com

Conditions Studied

Stress Disorders, Post-Traumatic

Interventions

  • DEVICE EEG-neurofeedback training
  • DEVICE Sham training

Study Locations (6)

New York

  • New York University Grossman School of Medicine - New York
  • University of Rochester Medical Center (URMC) - Rochester

Alabama

  • Birmingham VA Medical Center - Birmingham

Georgia

  • Atlanta VA Medical Center - Decatur

Massachusetts

  • Boston VA Healthcare System - Boston

South Carolina

  • Charleston VA Medical Center - Charleston

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2025-05-14
Est. Completion 2027-08
Phase NA
Foundation for Atlanta Veterans Education and Research

5 total trials

What NCT06770998 shows while recruiting

NCT06770998 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 152-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (64% higher).

The record links to 1 condition, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 2 interventions - of which EEG-neurofeedback training is the first listed.

NCT06770998 lists 6 locations in 5 states (New York, Alabama, Georgia).

Frequently Asked Questions

What is clinical trial NCT06770998 about?

NCT06770998 is a clinical study titled "A Study of a Novel EEG Neurofeedback System for PTSD Treatment". The goal of this clinical trial is to learn if training with the Prism system can reduce PTSD symptoms in US military Veterans and civilians with PTSD. Prism is a form of neurofeedback training that uses EEG signals to promote self-regulation of brain function. The main question this study aims to a...

What is the current status of trial NCT06770998?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2025-05-14. Estimated completion is 2027-08.

What conditions does trial NCT06770998 study?

This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic.

What interventions are being tested in trial NCT06770998?

The interventions under investigation include: EEG-neurofeedback training (DEVICE), Sham training (DEVICE).

Who is sponsoring clinical trial NCT06770998?

This trial is sponsored by Foundation for Atlanta Veterans Education and Research, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06770998 being conducted?

This trial has 6 study locations across Alabama, Georgia, Massachusetts, New York, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Stress Disorders, Post-Traumatic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06770998's enrollment target sits among peer trials

250 9th of 66 higher than 58 of 66 other Stress Disorders, Post-Traumatic trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stress Disorders, Post-Traumatic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06770998

Source: ClinicalTrials.gov NCT06770998, the US trial registry maintained by the National Library of Medicine. NCT06770998 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.